Prosecution Insights
Last updated: April 19, 2026
Application No. 17/793,862

ALKOXYSILYL GROUP-CONTAINING PERFLUOROPOLYETHER COMPOUND, AND COMPOSITION CONTAINING SAME

Final Rejection §103
Filed
Jul 19, 2022
Examiner
XU, JIANGTIAN
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Shin-Etsu Chemical Co. Ltd.
OA Round
2 (Final)
66%
Grant Probability
Favorable
3-4
OA Rounds
3y 3m
To Grant
99%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allow Rate
211 granted / 321 resolved
+0.7% vs TC avg
Strong +33% interview lift
Without
With
+33.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
64 currently pending
Career history
385
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
55.0%
+15.0% vs TC avg
§102
14.4%
-25.6% vs TC avg
§112
23.1%
-16.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 321 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 8-14 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected election, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 5/8/2025. Species (i), (iii) to (vii) in claim 3 are withdrawn. Response to Amendment The amendment filed on 9/5/2025 has been entered. Claim(s) 1-5 is/are currently amended. Claim(s) 7 has/have been cancelled. Claim(s) 1-6 and 8-14 is/are pending with claim(s) 8-14 withdrawn from consideration. Claim(s) 1-6 is/are under examination in this office action. Response to Arguments Applicant's argument filed on 9/5/2025, with respect to 103 rejection has been fully considered but is not persuasive. Applicant argued that the prior art does not teach the claimed structure X wherein 'a' is an integer of 0 or 1,'b' is an integer of 2 or 3 and 'c' is an integer of 0 such that a+b+c = 3, 'd' is an integer from 0 to 2, as shown in Yamane’s Example 6. In response, disclosed examples and preferred embodiments do not constitute a teaching away from a broader disclosure or nonpreferred embodiments; and patents are relevant as prior art for all they contain; nonpreferred and alternative embodiments constitute prior art (see MPEP 2123). In this case, Yamane teaches a fluorine-containing organopolysiloxane represented by formula (A), which can be PNG media_image1.png 403 951 media_image1.png Greyscale as stated in the 103 rejection. This structure meets the claimed formula (1) containing the claimed X wherein a=0, c=0, d=0, and b=3. Applicant argued that Yamane does not disclose that the inventive perfluoropolyether compound has solubility in saturated hydrocarbon solvents and provides a coating film with excellent water and oil repellency. In response, the recited solubility and water and oil repellency of a coating film are not part of the claim. Even if they are incorporated as claim limitations, they are properties of the product. “Products of identical chemical composition cannot have mutually exclusive properties." A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. “When the PTO shows a sound basis for believing that the products of the applicant and the prior art are the same, the applicant has the burden of showing that they are not.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990)). See MPEP 2112.01. Since the prior art teaches the same product as the current invention, the recited property is expected to be present. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-7 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yamane et al (US 20070149746 A1). Regarding claims 1-4, Yamane teaches a fluorine-containing organopolysiloxane represented by formula (A) SinR12n+2On-1 with examples of PNG media_image2.png 200 400 media_image2.png Greyscale PNG media_image3.png 200 400 media_image3.png Greyscale wherein R1 may be the same with or different from each other and is a hydrogen atom or a monovalent organic group, n is an integer of from 2 to 40 [0046-0050]. One of the SiOSi bond is replaced with a bond represented by the following formula (iii): Si-Q-Rf2-Q-Si (iii) [0054]. Therefore, the fluorine-containing organopolysiloxane (A) can have a structure of PNG media_image4.png 413 687 media_image4.png Greyscale At least two of the end-group R1 can be replaced with the following structure: PNG media_image5.png 200 400 media_image5.png Greyscale wherein R3 is an alkyl group (e.g., Me), y is an integer of from 1 to 5 and a is 2 or 3, X is a hydrolyzable group (e.g., OMe), a is 2 or 3 [0029-0030, 0052]. When y=2, R3 is Me, a=3, X=OMe, the above structure is C2H4-Si-(OMe)3 (the C2H4- reads on the claimed Q1 as specified in claim 4), and the fluorine-containing organopolysiloxane (A) can have a structure of PNG media_image6.png 398 941 media_image6.png Greyscale In the above structure, Rf2 is a divalent group containing a perfluoroether residue including formula (5) PNG media_image7.png 200 400 media_image7.png Greyscale wherein Y can be F, which may be different with each other, and r is an integer of from 2 to 6, d is an integer of from 1 to 3, each m and n is an integer of from 0 to 200 with m+n ranging from 2 to 200, s is an integer of from 0 to 6 [0069-0070]. When d=2, m=0, r=1, Rf2 of formula (5) becomes -CF2O(CF2O)s(CF2CF2O)nCF2- which is equivalent to the claimed PFPE of formula (3) specified in claim 2, with s corresponding to the claimed a1, n corresponding to the claimed b1. Q is a divalent organic group including -C(=O)NH-CH2CH2CH2- [0073], which is equivalent to the claimed Z specified in claim 3. When R1=Me, the fluorine-containing organopolysiloxane (A) becomes the claimed formula (1) containing the recited X of formula (2): PNG media_image1.png 403 951 media_image1.png Greyscale wherein the recited a=0, c=0, d=0, and b=3. It would have been obvious to one of ordinary skill in the art at the time of filing to select the above structure as Yamane’s fluorine-containing organopolysiloxane (A), as it is expressly disclosed as being useful in this capacity. It has been established that selection of a known material based on its suitability for its intended use is prima facie obvious (Sinclair & Carroll Co. v. Interchemical Corp., 325 U.S. 327, 65 USPQ 297 (1945)). See MPEP 2144.07. Regarding claims 5-6, since c=0, the claimed Q2 is not present. Since d=0, the claimed G is not present. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JIANGTIAN XU whose telephone number is (571)270-1621. The examiner can normally be reached Monday-Thursday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached on (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JIANGTIAN XU/Primary Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Jul 19, 2022
Application Filed
Jun 03, 2025
Non-Final Rejection — §103
Sep 05, 2025
Response Filed
Oct 21, 2025
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12595323
VINYL ACETATE-BASED COPOLYMER DISPERSIONS WITH SMALL PARTICLE SIZE
2y 5m to grant Granted Apr 07, 2026
Patent 12588676
EPOXIDIZED OIL-BASED SURFACTANT AND COMPOSITIONS COMPRISING THE SAME
2y 5m to grant Granted Mar 31, 2026
Patent 12584272
SACCHARIDE FATTY ACID ESTER LATEX BARRIER COATING COMPOSITIONS
2y 5m to grant Granted Mar 24, 2026
Patent 12583969
METHOD FOR THE CONTINUOUS PREPARATION OF POLYAMIDE PREPOLYMERS
2y 5m to grant Granted Mar 24, 2026
Patent 12577445
DISPERSION ADHESIVES
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
66%
Grant Probability
99%
With Interview (+33.3%)
3y 3m
Median Time to Grant
Moderate
PTA Risk
Based on 321 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month